| Royal Philips. (4/8/21). "Press Release: Philips and Ibex Medical Analytics Team to Accelerate Adoption of AI-powered Digital Pathology". Amsterdam & Tel Aviv. |
2021-04-08 |
| Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. |
2021-03-26 |
| Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams |
2021-03-25 |
| Lava Therapeutics B.V.. (3/24/21). "Press Release: Lava Therapeutics Announces Pricing of Initial Public Offering". Utrecht & Philadelphia, PA. |
2021-03-24 |
| Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". |
2021-03-23 |
| Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. |
2021-03-18 |
| Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
| ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium. |
2021-03-16 |
| Lava Therapeutics B.V.. (3/15/21). "Press Release: Lava Therapeutics B.V. Appoints Edward F. Smith as Chief Financial Officer". Utrecht & Philadelphia, PA. |
2021-03-15 |
| Univercells S.A.. (3/15/21). "Press Release: Univercells, Univercells Technologies and Gamma Biosciences Announce Mathias Garny as New CEO of Univercells Technologies". Brussels. |
2021-03-15 |
| AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. |
2021-03-10 |
| Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
| Royal Philips. (3/2/21). "Press Release: Shez Partovi to Succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer". Amsterdam. |
2021-03-02 |
| Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. |
2021-03-01 |
| Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. |
2021-03-01 |
| Osborne Clarke. (2/25/21). "Press Release: Osborne Clarke Advised Delphi Genetics on Its Acquisition by Catalent". |
2021-02-25 |
| Catalent. (2/23/21). "Press Release: Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities". Somerset, NJ & Gosselies. |
2021-02-23 |
| Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. |
2021-02-23 |
| InteRNA Technologies B.V.. (2/16/21). "Press Release: InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors". Utrecht. |
2021-02-16 |
| CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. |
2021-02-12 |
| Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. |
2021-02-10 |
| Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen. |
2021-02-10 |
| Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". |
2021-02-08 |
| Tecan Group Ltd.. (2/4/21). "Press Release: Tecan and UgenTec Partner to Offer Sample-to-result Solutions for qPCR". Männedorf. |
2021-02-04 |
| V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. |
2021-02-04 |
| GlaxoSmithKline plc. (2/3/21). "Press Release: GSK and CureVac to Develop Next Generation mRNA COVID-19 Vaccines". London, Tübingen & Boston, MA. |
2021-02-03 |
| Hyloris Pharmaceuticals S.A.. (2/3/21). "Press Release: Hyloris Appoints Marieke Vermeersch as VP of Investor Relations and Corporate Communications". Liège. |
2021-02-03 |
| Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". |
2021-02-03 |
| Nyxoah S.A.. (2/2/21). "Press Release: Nyxoah and Vanderbilt University Enter Exclusive Licensing Agreement Regarding Next Generation Neurostimulation Technologies to Treat Obstructive Sleep Apnea (OSA)". Mont-Saint-Guibert. |
2021-02-02 |
| Argen-X N.V. (Argenx). (2/2/21). "Press Release: Argenx Raises $1.0 Billion in Gross Proceeds in a Global Offering". Breda. |
2021-02-02 |
| CureVac N.V.. (1/28/21). "Press Release: CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares". Tübingen & Boston, MA. |
2021-01-28 |
| Medigene AG. (1/28/21). "Press Release: Focus on Solid Tumors – Discontinuation of MDG1021 Development Program". Planegg-Martinsried. |
2021-01-28 |
| High-Tech Gründerfonds Management GmbH. (1/26/21). "Press Release: GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases". |
2021-01-26 |
| CureVac N.V.. (1/25/21). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. |
2021-01-25 |
| BiondVax Pharmaceuticals Ltd.. (1/21/21). "Press Release: BiondVax Announces Appointment of Amir Reichman as New CEO". Jerusalem. |
2021-01-21 |
| Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-21 |
| Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. |
2021-01-20 |
| Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. |
2021-01-19 |
| Merus N.V.. (1/19/21). "Press Release: Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies". Indianapolis, IN & Utrecht. |
2021-01-19 |
| Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA. |
2021-01-19 |
| Affimed N.V.. (1/15/21). "Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. |
2021-01-15 |
| Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA. |
2021-01-15 |
| Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. |
2021-01-15 |
| NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. |
2021-01-14 |
| UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA. |
2021-01-13 |
| Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. |
2021-01-12 |
| Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares". Heidelberg. |
2021-01-12 |
| Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. |
2021-01-11 |
| Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg. |
2021-01-11 |
| Qiagen N.V.. (1/8/21). "Press Release: Qiagen Announces Appointment of New Supervisory Board Member". Venlo. |
2021-01-08 |
| CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA. |
2021-01-07 |
| Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. |
2021-01-07 |
| BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. |
2021-01-07 |
| Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. |
2021-01-07 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/6/21). "Press Release: Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms". Bilthoven & Maastricht. |
2021-01-06 |
| Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA. |
2021-01-06 |
| Argenx SE. (1/6/21). "Press Release: Argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China". Breda, Shanghai & San Francisco, CA. |
2021-01-06 |
| Volta Medical. (1/5/21). "Press Release: Volta Medical Raises 28 Million USD to Revolutionize Persistent AFib Ablation". Marseille. |
2021-01-05 |
| MiNA Therapeutics Ltd.. (1/5/21). "Press Release: MiNA Therapeutics Appoints Robin Wright as Chief Financial Officer". London. |
2021-01-05 |
| Siemens Healthineers AG. (1/5/21). "Press Release: Siemens Healthineers Proposes Peer Schatz to Annual Shareholders' Meeting as New Supervisory Board Member". Erlangen. |
2021-01-05 |
| Argenx SE. (1/4/21). "Press Release: Argenx to Present at 39th Annual J.P. Morgan Healthcare Conference". Breda & Ghent. |
2021-01-04 |
| BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-21 |
| Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. |
2020-12-21 |
| BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-21 |
| Swedish Orphan Biovitrum AB. (12/21/20). "Press Release: Sobi Appoints New Head of North America Ahead of Launch Phase". |
2020-12-21 |
| Univercells S.A.. (12/17/20). "Press Release: Univercells Holding Raises €70 Million in Series C Financing". Brussels. |
2020-12-17 |
| Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen. |
2020-12-15 |
| Locanabio, Inc.. (12/14/20). "Press Release: Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNATargeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases". San Diego, CA. |
2020-12-14 |
| [iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. |
2020-12-10 |
| Sebia S.A.. (12/9/20). "Press Release: Sebia Enters into License Agreement with Erasmus MC and Radboudumc to Provide Minimal Residual Disease Test from Serum Samples of Multiple Myeloma Patients". Paris. |
2020-12-09 |
| CureVac N.V.. (12/9/20). "Press Release: CureVac and Fareva Sign Agreement for Fill & Finish Manufacturing of Curevac’s COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. |
2020-12-09 |
| Forbion Capital Partners. (12/8/20). "Press Release: Forbion Secures EUR 460 Million for Oversubscribed Fifth Fund". Naarden & Munich. |
2020-12-08 |
| Centogene N.V.. (12/8/20). "Press Release: Centogene and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)". Cambridge, MA, Rostock, Berlin & Munich. |
2020-12-08 |
| CureVac N.V.. (12/4/20). "Press Release: CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer". Tübingen & Boston, MA. |
2020-12-04 |
| Noema Pharma AG. (12/1/20). "Press Release: Noema Pharma Raises CHF54 Million in Series A Financing Round Led by Sofinnova Partners and Polaris Partners". Basel. |
2020-12-01 |
| Atbtherapeutics. (12/1/20). "Press Release: Atbtherapeutics Initiates Agreement with iBio CDMO to Manufacture Game-changer atbodies to Better Treat Cancer". Marche-en-Famenne. |
2020-12-01 |
| Salesforce.com Inc.. (12/1/20). "Press Release: Salesforce Signs Definitive Agreement to Acquire Slack". San Francisco, CA. |
2020-12-01 |
| [iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. |
2020-11-30 |
| Innatera Nanosystems B.V.. (11/25/20). "Press Release: Innatera Raises €5M to Bring Neuromorphic Intelligence to the Sensor-edge". Delft. |
2020-11-25 |
| Novalis Biotech. (11/23/20). "Press Release: Novalis Biotech Announces First Closing of Its Second Healthcare Fund. €8 Million Raised for Novalis Biotech Acceleration Fund". Ghent. |
2020-11-23 |
| Galapagos N.V.. (11/23/20). "Press Release: Selvita to Acquire Fidelta from Galapagos". Mechelen & Krakow. |
2020-11-23 |
| Achilles Therapeutics Ltd.. (11/19/20). "Press Release: Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours". Stevenage. |
2020-11-19 |
| SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin. |
2020-11-19 |
| Pharvaris B.V.. (11/18/20). "Press Release: Pharvaris Announces $80 Million Series C Financing to Advance Novel Oral Bradykinin-B2-Receptor Antagonists for the Treatment of HAE". Zug. |
2020-11-18 |
| Immunicum AB. (11/18/20). "Press Release: Immunicum AB and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies". |
2020-11-18 |
| BioCheck B.V.. (11/17/20). "Press Release: BioChek Group Announces Thomas Struckmeyer as New CEO". Reeuwijk. |
2020-11-17 |
| Sophia Genetics S.A.. (11/17/20). "Press Release: Bram Goorden Joins Sophia Genetics as Chief Commercial Officer and Head of North America". Boston, MA & Lausanne. |
2020-11-17 |
| OncoDNA S.A.. (11/17/20). "Press Release: Successful Friendly Takeover Bid Initiated by OncoDNA on IntegraGen’s Shares". |
2020-11-17 |
| Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases". |
2020-11-16 |
| UCB S.A.. (11/12/20). "Press Release: UCB Strengthens Its Gene Therapy Activities with Additional Pipeline Programs, Capabilities and Platforms". Brussels. |
2020-11-12 |
| Medigene AG. (11/12/20). "Press Release: Medigene Provides Q3 2020 Update". Planegg-Martinsried. |
2020-11-12 |
| Apaxen S.A.. (11/12/20). "Press Release: Belgian Biotech Apaxen Appoints Bart Wuurman as CEO". Gosselies. |
2020-11-12 |
| BioNTech SE. (11/11/20). "Press Release: Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19". New York, NY & Mainz. |
2020-11-11 |
| Catalym GmbH. (11/10/20). "Press Release: Catalym Raises EUR50 Million to Advance GDF-15 Antibody into Clinical Trials for Checkpoint-inhibitor Refractory Patients". Munich. |
2020-11-10 |
| Pharming Group N.V.. (11/09/20). "Press Release: Pharming Appoints Jeroen Wakkerman as Chief Financial Officer". Leiden. |
2020-11-09 |
| [iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen. |
2020-11-08 |
| Galapagos N.V.. (11/5/20). "Press Release: OncoArendi and Galapagos Enter into Exclusive Collaboration on Chitinase Inhibitors in Fibrosis". Mechelen & Warsaw. |
2020-11-05 |
| The Protein Brewery B.V.. (11/3/20). "Press Release: The Protein Brewery Raises € 22 Million Series A investment". Breda. |
2020-11-03 |
| EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels. |
2020-11-02 |
| Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam. |
2020-11-02 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
